🇺🇸 FDA
Patent

US 6921761

Gonadotropin-releasing hormone receptor antagonists and methods relating thereto

expired A61PA61P1/04A61P13/08

Quick answer

US patent 6921761 (Gonadotropin-releasing hormone receptor antagonists and methods relating thereto) held by Neurocrine Biosciences, Inc. expires Mon Jul 21 2025 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
Neurocrine Biosciences, Inc.
Grant date
Tue Jul 26 2005 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 21 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61P, A61P1/04, A61P13/08, A61P15/00, A61P15/08